O-I Glass (OI) 10-Q 29 Apr 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015
Document and Entity Information
Entity Registrant Name	OWENS ILLINOIS INC /DE/
Entity Central Index Key	812074
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	161,250,610
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

CONDENSED_CONSOLIDATED_RESULTS

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
CONSOLIDATED RESULTS OF OPERATIONS
Net sales	$1,421	$1,639
Cost of goods sold	-1,153	-1,318
Gross profit	268	321
Selling and administrative expense	-124	-133
Research, development and engineering expense	-15	-15
Interest expense, net	-47	-54
Equity earnings	15	16
Other income (expense), net	3	-1
Earnings from continuing operations before income taxes	100	134
Provision for income taxes	-25	-27
Earnings from continuing operations	75	107
Loss from discontinued operations		-1
Net earnings	75	106
Net earnings attributable to noncontrolling interests	-4	-5
Net earnings attributable to the Company	71	101
Amounts attributable to the Company:
Earnings from continuing operations	71	102
Loss from discontinued operations		-1
Net earnings	$71	$101
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$0.44	$0.62
Loss from discontinued operations (in dollars per share)		($0.01)
Net earnings (in dollars per share)	$0.44	$0.61
Weighted average shares outstanding (thousands) (in shares)	162,146	164,760
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	$0.44	$0.62
Loss from discontinued operations (in dollars per share)		($0.01)
Net earnings (in dollars per share)	$0.44	$0.61
Weighted average diluted shares outstanding (thousands) (in shares)	163,287	166,165

CONDENSED_CONSOLIDATED_COMPREH

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
CONSOLIDATED COMPREHENSIVE INCOME
Net earnings	$75	$106
Other comprehensive income:
Foreign currency translation adjustments	-257	32
Pension and other postretirement benefit adjustments, net of tax	37	23
Change in fair value of derivative instruments		1
Other comprehensive income (loss)	-220	56
Total comprehensive income (loss)	-145	162
Comprehensive income attributable to noncontrolling interests		-2
Comprehensive income (loss) attributable to the Company	($145)	$160

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Current assets:
Cash and cash equivalents	$257	$512	$201
Receivables	861	744	1,078
Inventories	1,007	1,035	1,204
Prepaid expenses	74	80	94
Total current assets	2,199	2,371	2,577
Other assets:
Property, plant and equipment, net	2,337	2,445	2,634
Goodwill	1,752	1,893	2,059
Other assets	1,038	1,149	1,218
Total assets	7,326	7,858	8,488
Current liabilities:
Short-term loans and long-term debt due within one year	637	488	331
Current portion of asbestos-related liabilities	143	143	150
Accounts payable	919	1,137	1,074
Other liabilities	417	560	527
Total current liabilities	2,116	2,328	2,082
Long-term debt	2,984	2,972	3,371
Asbestos-related liabilities	278	292	283
Other long-term liabilities	920	991	992
Share owners' equity:
Share owners' equity	1,028	1,275	1,760
Total liabilities and share owners' equity	$7,326	$7,858	$8,488

CONDENSED_CONSOLIDATED_CASH_FL

CONDENSED CONSOLIDATED CASH FLOWS (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net earnings	$75	$106
Loss from discontinued operations		1
Non-cash charges:
Depreciation and amortization	95	111
Pension expense	7	15
Pension contributions	-4	-5
Asbestos-related payments	-15	-15
Cash paid for restructuring activities	-10	-21
Change in components of working capital	-429	-352
Other, net (a)	3	-42
Cash utilized in continuing operating activities	-278	-202
Cash utilized in discontinued operating activities		-1
Total cash utilized in operating activities	-278	-203
Cash flows from investing activities:
Additions to property, plant and equipment	-106	-108
Acquisitions, net of cash acquired	-52
Other, net	1	14
Cash utilized in investing activities	-157	-94
Cash flows from financing activities:
Changes in borrowings, net	308	136
Issuance of common stock		4
Treasury shares purchased	-100
Distributions paid to noncontrolling interests		-19
Other, net	-1
Cash provided by financing activities	207	121
Effect of exchange rate fluctuations on cash	-27	-6
Decrease in cash	-255	-182
Cash at beginning of period	512	383
Cash at end of period	$257	$201

Segment_Information

Segment Information	3 Months Ended
	Mar. 31, 2015
Segment Information
Segment Information	1.Segment Information
	The Company has four reportable segments based on its geographic locations:  Europe, North America, South America and Asia Pacific.  These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations.  Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other.  These include licensing, equipment manufacturing, global engineering, and certain equity investments.  Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.
	The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs.  The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources.  Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided.
	Financial information for the three-months ended March 31, 2015 and 2014 regarding the Company’s reportable segments is as follows:
		2015			2014
	Net sales:
	Europe	$	567		$	706
	North America	470			485
	South America	205			239
	Asia Pacific	163			203
	Reportable segment totals	1,405			1,633
	Other	16			6
	Net sales	$	1,421		$	1,639
		2015			2014
	Segment operating profit:
	Europe	$	49		$	87
	North America	71			65
	South America	30			41
	Asia Pacific	18			25
	Reportable segment totals	168			218
	Items excluded from segment operating profit:
	Retained corporate costs and other	(21		)	(30		)
	Interest expense, net	(47		)	(54		)
	Earnings from continuing operations before income taxes	$	100		$	134
	Financial information regarding the Company’s total assets is as follows:
		March 31,			December 31,			March 31,
		2015			2014			2014
	Total assets:
	Europe	$	2,935		$	3,223		$	3,585
	North America	2,033			1,971			2,055
	South America	1,097			1,300			1,453
	Asia Pacific	942			1,018			1,142
	Reportable segment totals	7,007			7,512			8,235
	Other	319			346			253
	Consolidated totals	$	7,326		$	7,858		$	8,488

Receivables

Receivables	3 Months Ended
	Mar. 31, 2015
Receivables
Receivables
	2.  Receivables
	Receivables consist of the following:
		March 31,		December 31,		March 31,
		2015		2014		2014
	Trade accounts receivable	$	697	$	583	$	911
	Less: allowances for doubtful accounts and discounts	31		34		39
	Net trade receivables	666		549		872
	Other receivables	195		195		206
		$	861	$	744	$	1,078
	The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows.  The amount of receivables sold by the Company was $219 million, $276 million, and $151 million at March 31, 2015, December 31, 2014, and March 31, 2014, respectively.  Any continuing involvement with the sold receivables is immaterial.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2015
Inventories
Inventories	3.  Inventories
	Major classes of inventory are as follows:
		March 31,		December 31,		March 31,
		2015		2014		2014
	Finished goods	$	858	$	884	$	1,037
	Raw materials	109		110		121
	Operating supplies	40		41		46
		$	1,007	$	1,035	$	1,204

Derivative_Instruments

Derivative Instruments	3 Months Ended
	Mar. 31, 2015
Derivative Instruments
Derivative Instruments
	4. Derivative Instruments
	The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign exchange option and forward contracts.  The Company uses an income approach to valuing these contracts.  Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models.  These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.  The Company also evaluates counterparty risk in determining fair values.
	Commodity Forward Contracts Designated as Cash Flow Hedges
	In North America, the Company enters into commodity forward contracts related to forecasted natural gas requirements, the objectives of which are to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows. The Company continually evaluates the natural gas market and related price risk and periodically enters into commodity forward contracts in order to hedge a portion of its usage requirements. The majority of the sales volume in North America is tied to customer contracts that contain provisions that pass the price of natural gas to the customer.  In certain of these contracts, the customer has the option of fixing the natural gas price component for a specified period of time.  At March 31, 2015 and 2014, the Company had entered into commodity forward contracts covering approximately 5,400,000 MMBTUs and 4,400,000 MMBTUs, respectively, primarily related to customer requests to lock the price of natural gas.
	The Company accounts for the above forward contracts as cash flow hedges at March 31, 2015 and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings.  An unrecognized loss of less than $1 million at March 31, 2015 and an unrecognized gain of $2 million at March 31, 2014 related to the commodity forward contracts was included in Accumulated OCI, and will be reclassified into earnings over the next twelve to twenty-four months.  Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings.  The ineffectiveness related to these natural gas hedges for the three months ended March 31, 2015 and 2014 was not material.
	The effect of the commodity forward contracts on the results of operations for the three months ended March 31, 2015 and 2014 is as follows:
							Amount of Gain
	Amount of Gain						Reclassified from
	Recognized in OCI on						Accumulated OCI into Income
	Commodity Forward Contracts						(reported in Cost of goods sold)
	(Effective Portion)						(Effective Portion)
	2015			2014			2015			2014
	$	—		$	2		$	—		$	1
	Forward Exchange Derivative Contracts not Designated as Hedging Instruments
	The Company may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. Subsidiaries may also use forward exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables, payables and loans, not denominated in, or indexed to, their functional currencies. The Company records these short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings.
	At March 31, 2015 and 2014, various subsidiaries of the Company had outstanding forward exchange and option agreements denominated in various currencies covering the equivalent of approximately $532 million and $670 million, respectively, related primarily to intercompany transactions and loans.
	The effect of the forward exchange derivative contracts on the results of operations for the three months ended March 31, 2015 and 2014 is as follows:
			Amount of Gain (Loss)
	Location of Gain (Loss)		Recognized in Income on
	Recognized in Income on		Forward Exchange Contracts
	Forward Exchange Contracts		2015			2014
	Other expense, net		$	11		$	(1	)
	Balance Sheet Classification
	The Company records the fair values of derivative financial instruments on the balance sheet as follows: (a) receivables if the instrument has a positive fair value and maturity within one year, (b) other assets if the instrument has a positive fair value and maturity after one year, (c) other liabilities (current) if the instrument has a negative fair value and maturity within one year, and (d) other long-term liabilities if the instrument has a negative fair value and maturity after one year.  The following table shows the amount and classification (as noted above) of the Company’s derivatives:
			Balance		Fair Value
			Sheet		March 31,			December 31,			March 31,
			Location		2015			2014			2014
	Asset Derivatives:
	Derivatives designated as hedging instruments:
	Commodity forward contracts		a		$	—		$	—		$	2
	Derivatives not designated as hedging instruments:
	Foreign exchange derivative contracts		a		21			10			4
	Foreign exchange derivative contracts		c								3
	Total derivatives not designated as hedging instruments				21			10			7
	Total asset derivatives				$	21		$	10		$	9
	Liability Derivatives:
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		c		$	2		$	4		$	10
	Total liability derivatives				$	2		$	4		$	10

Restructuring_Accruals

Restructuring Accruals	3 Months Ended
	Mar. 31, 2015
Restructuring Accruals
Restructuring Accruals	5.  Restructuring Accruals
	Selected information related to the restructuring accruals for the three months ended March 31, 2015 and 2014 is as follows:
		European			Asia Pacific			Other			Total
		Asset			Restructuring			Restructuring			Restructuring
		Optimization						Actions
	Balance at January 1, 2015	$	12		$	12		$	36		$	60
	Net cash paid, principally severance and related benefits				(1		)	(9		)	(10		)
	Other, including foreign exchange translation	(1		)	(1		)	(2		)	(4		)
	Balance at March 31, 2015	$	11		$	10		$	25		$	46
	Balance at January 1, 2014	$	30		$	20		$	64		$	114
	Net cash paid, principally severance and related benefits	(2		)	(4		)	(15		)	(21		)
	Other, including foreign exchange translation	(1		)	(4		)	(3		)	(8		)
	Balance at March 31, 2014	$	27		$	12		$	46		$	85
	The Company’s decisions to curtail selected production capacity have resulted in write downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell.  The Company classified the significant assumptions used to determine the fair value of the impaired assets, which was not material, as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.

Pension_Benefit_Plans

Pension Benefit Plans	3 Months Ended
	Mar. 31, 2015
Pension Benefit Plans.
Pension Benefit Plans	6.  Pension Benefit Plans
	The components of the net periodic pension cost for the three months ended March 31, 2015 and 2014 are as follows:
		U.S.						Non-U.S.
		2015			2014			2015			2014
	Service cost	$	6		$	6		$	4		$	7
	Interest cost	24			27			12			18
	Expected asset return	(42		)	(43		)	(21		)	(22		)
	Amortization:
	Actuarial loss	19			18			5			4
	Net periodic pension cost	$	7		$	8		$	—		$	7

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Taxes
Income Taxes
	7.  Income Taxes
	The Company performs a quarterly review of the annual effective tax rate and makes changes if necessary based on new information or events. The estimated annual effective tax rate is forecasted quarterly using actual historical information and forward-looking estimates. The estimated annual effective tax rate may fluctuate due to changes in forecasted annual operating income; changes in the forecasted mix of earnings by country; changes to the valuation allowance for deferred tax assets (such changes would be recorded discretely in the quarter in which they occur); changes to actual or forecasted permanent book to tax differences (non-deductible expenses); impacts from future tax settlements with state, federal or foreign tax authorities (such changes would be recorded discretely in the quarter in which they occur); or impacts from tax law changes. To the extent such changes impact deferred tax assets/liabilities, these changes would generally be recorded discretely in the quarter in which they occur.  Additionally, the annual effective tax rate differs from the statutory U.S. Federal tax rate of 35% primarily because of valuation allowances in some jurisdictions and varying non-U.S. tax rates.
	In the U.S., the Company had experienced cumulative losses in previous years and has recorded a valuation allowance against its deferred tax assets. The Company’s U.S. operations are in a three-year cumulative income position, but this is not solely determinative of the need for a valuation allowance. The Company considered this factor and all other available positive and negative evidence and concluded that it is still more likely than not that the net deferred tax assets in the U.S. will not be realized, and accordingly continued to record a valuation allowance. The evidence considered included the magnitude of the current three-year cumulative income compared to historical losses, expected impact of tax planning strategies, interest rates, and the overall business environment. The Company continues to evaluate its cumulative income position and income trend as well as its future projections of sustained profitability and whether this profitability trend constitutes sufficient positive evidence to support a reversal of the valuation allowance (in full or in part). The amount of the valuation allowance recorded in the U.S. as of December 31, 2014 was $927 million.

Debt

Debt	3 Months Ended
	Mar. 31, 2015
Debt
Debt
	8.  Debt
	The following table summarizes the long-term debt of the Company:
		March 31,			December 31,			March 31,
		2015			2014			2014
	Secured Credit Agreement:
	Revolving Credit Facility:
	Revolving Loans	$	264		$	—		$	150
	Term Loans:
	Term Loan B	390			405			405
	Term Loan C (76 million CAD at March 31, 2015)	59			70			74
	Term Loan D (€85 million at March 31, 2015)	91			103			116
	Senior Notes:
	3.00%, Exchangeable, due 2015	18			18			621
	7.375%, due 2016	597			596			594
	6.75%, due 2020 (€500 million)	539			608			688
	4.875%, due 2021 (€330 million)	356			401			454
	5.00%, due 2022	494			494
	5.375%, due 2025	296			296
	Senior Debentures:
	7.80%, due 2018	250			250			250
	Capital Leases	66			63			38
	Other	24			29			22
	Total long-term debt	3,444			3,333			3,412
	Less amounts due within one year	460			361			41
	Long-term debt	$	2,984		$	2,972		$	3,371
	On May 19, 2011, the Company’s subsidiary borrowers entered into the Secured Credit Agreement (the “Prior Agreement”).  At March 31, 2015, the Prior Agreement included a $900 million revolving credit facility, a $390 million term loan, a 76 million Canadian dollar term loan, and a €85 million term loan, each of which had a final maturity date of May 19, 2016.  At March 31, 2015, the Company’s subsidiary borrowers had unused credit of $558 million available under the Prior Agreement.  The weighted average interest rate on borrowings outstanding under the Prior Agreement at March 31, 2015 was 1.70%.
	On April 22, 2015, the Company’s subsidiary borrowers entered into a new Senior Secured Credit Facility (the “New Agreement”), which amended and restated the Prior Agreement.  The New Agreement includes a $300 million revolving credit facility, a $600 million multicurrency revolving credit facility, a $600 million term loan, a €279 million term loan and a $300 million delayed draw term loan available until October 22, 2015, each of which has a final maturity date of April 22, 2020.  The proceeds from the New Agreement were used to repay all outstanding amounts under the Prior Agreement and will be available for other general corporate purposes, including the repayment of other existing indebtedness.
	The New Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.
	The New Agreement also contains one financial maintenance covenant, a Leverage Ratio, that requires the Company not to exceed a ratio of 4.0x calculated by dividing consolidated total debt, less cash and cash equivalents, by Consolidated EBITDA, as defined in the New Agreement.  The maximum Leverage Ratio is subject to an increase of 0.5x for the four fiscal quarters following the consummation of certain qualifying acquisitions as defined in the New Agreement.  The Leverage Ratio could restrict the ability of the Company to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Leverage Ratio to exceed the specified maximum.
	Failure to comply with these covenants and restrictions could result in an event of default under the New Agreement.  In such an event, the Company could not request borrowings under the revolving facility, and all amounts outstanding under the New Agreement, together with accrued interest, could then be declared immediately due and payable.  If an event of default occurs under the New Agreement and the lenders cause all of the outstanding debt obligations under the New Agreement to become due and payable, this would result in a default under a number of other outstanding debt securities and could lead to an acceleration of obligations related to these debt securities.  A default or event of default under the New Agreement, indentures or agreements governing other indebtedness could also lead to an acceleration of debt under other debt instruments that contain cross acceleration or cross-default provisions.
	The Leverage Ratio also determines pricing under the New Agreement.  The interest rate on borrowings under the New Agreement is, at the Company’s option, the Base Rate or the Eurocurrency Rate, as defined in the New Agreement.  These rates include a margin linked to the Leverage Ratio.  The margins range from 1.25% to 1.75% for Eurocurrency Rate loans and from 0.25% to 0.75% for Base Rate loans.  In addition, a fee is payable on the revolving credit facility commitments ranging from 0.20% to 0.30% per annum linked to the Leverage Ratio.  As of March 31, 2015, the Company was in compliance with all covenants and restrictions in the Prior Agreement.  In addition, the Company believes that it will remain in compliance and that its ability to borrow funds under the New Agreement will not be adversely affected by the covenants and restrictions.
	Borrowings under the New Agreement are secured by substantially all of the assets, excluding real estate, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries.  Borrowings are also secured by a pledge of certain of intercompany debt and equity in most of the Company’s domestic subsidiaries and, in the case of foreign borrowings, of stock of certain foreign subsidiaries.  All borrowings under the New Agreement are guaranteed by certain domestic subsidiaries of the Company for the term of the New Agreement.
	During December 2014, the Company issued senior notes with a face value of $500 million that bear interest at 5.00% and are due January 15, 2022 (the “Senior Notes due 2022”).  The Company also issued senior notes with a face value of $300 million that bear interest at 5.375% and are due January 15, 2025 (the “Senior Notes due 2025,” and together with the Senior Notes due 2022, the “New Senior Notes”).  The New Senior Notes were issued via a private placement and are guaranteed by substantially all of the Company’s domestic subsidiaries.  The net proceeds from the New Senior Notes, after deducting debt issuance costs, totaled approximately $790 million and were used to purchase $611 million aggregate principal amount of the Company’s 3.00% 2015 Exchangeable Senior Notes.  Approximately $18 million aggregate principal amount of the Company’s 3.00% 2015 Exchangeable Senior Notes remain outstanding as of March 31, 2015.
	The Company has a €215 million European accounts receivable securitization program, which extends through September 2016, subject to periodic renewal of backup credit lines.
	Information related to the Company’s accounts receivable securitization program is as follows:
		March 31,			December 31,			March 31,
		2015			2014			2014
	Balance (included in short-term loans)	$	171		$	122		$	253
	Weighted average interest rate	1.36		%	1.41		%	1.53		%
	The carrying amounts reported for the accounts receivable securitization program, and certain long-term debt obligations subject to frequently redetermined interest rates, approximate fair value.  Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy.
	Fair values at March 31, 2015 of the Company’s significant fixed rate debt obligations are as follows:
					Indicated
		Principal			Market		Fair
		Amount			Price		Value
	Senior Notes:
	7.375%, due 2016	$	600		105.88		$	635
	6.75%, due 2020 (€500 million)	539			120.91		652
	4.875%, due 2021 (€330 million)	356			112.33		400
	5.00%, due 2022	500			102.63		513
	5.375%, due 2025	300			103.13		309
	Senior Debentures:
	7.80%, due 2018	250			112.56		281

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2015
Contingencies
Contingencies
	9.  Contingencies
	Asbestos
	The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure to asbestos dust.  From 1948 to 1958, one of the Company’s former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos.  The Company exited the pipe and block insulation business in April 1958.  The typical asbestos personal injury lawsuit alleges various theories of liability, including negligence, gross negligence and strict liability and seeks compensatory and in some cases, punitive damages in various amounts (herein referred to as “asbestos claims”).
	As of March 31, 2015, the Company has determined that it is a named defendant in asbestos lawsuits and claims involving approximately 2,200 plaintiffs and claimants.  Based on an analysis of the lawsuits pending as of December 31, 2014, approximately 81% of plaintiffs either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to invoke the jurisdictional minimum of the trial court.  Approximately 13% of plaintiffs specifically plead damages above the jurisdictional minimum up to, and including, $15 million or less, and 5% of plaintiffs specifically plead damages greater than $15 million but less than $100 million.  Fewer than 1% of plaintiffs specifically plead damages equal to or greater than $100 million.
	As indicated by the foregoing summary, current pleading practice permits considerable variation in the assertion of monetary damages.  The Company’s experience resolving hundreds of thousands of asbestos claims and lawsuits over an extended period demonstrates that the monetary relief that may be alleged in a complaint bears little relevance to a claim’s merits or disposition value.  Rather, the amount potentially recoverable is determined by such factors as the severity of the plaintiff’s asbestos disease, the product identification evidence against the Company and other defendants, the defenses available to the Company and other defendants, the specific jurisdiction in which the claim is made, and the plaintiff’s medical history and exposure to other disease-causing agents.
	In addition to the pending claims set forth above, the Company has claims-handling agreements in place with many plaintiffs’ counsel throughout the country.  These agreements require evaluation and negotiation regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for such claims include verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company’s former business unit during its manufacturing period ending in 1958.
	The Company has also been a defendant in other asbestos-related lawsuits or claims involving maritime workers, medical monitoring claimants, co-defendants and property damage claimants.  Based upon its past experience, the Company believes that these categories of lawsuits and claims will not involve any material liability and they are not included in the above description of pending matters or in the following description of disposed matters.
	Since receiving its first asbestos claim, the Company as of March 31, 2015, has disposed of the asbestos claims of approximately 395,000 plaintiffs and claimants at an average indemnity payment per claim of approximately $8,900.  Certain of these dispositions have included deferred amounts payable.  Deferred amounts payable totaled approximately $16 million at March 31, 2015 ($13 million at December 31, 2014) and are included in the foregoing average indemnity payment per claim.  The Company’s asbestos indemnity payments have varied on a per claim basis, and are expected to continue to vary considerably over time.  As discussed above, a part of the Company’s objective is to achieve, where possible, resolution of asbestos claims pursuant to claims-handling agreements.  Failure of claimants to meet certain medical and product exposure criteria in the Company’s administrative claims handling agreements has generally reduced the number of claims that would otherwise have been received by the Company in the tort system.  In addition, certain courts and legislatures have reduced or eliminated the number of claims that the Company otherwise would have received by the Company in the tort system.  These developments generally have had the effect of increasing the Company’s per-claim average indemnity payment over time.
	The Company believes that its ultimate asbestos-related liability (i.e., its indemnity payments or other claim disposition costs plus related legal fees) cannot reasonably be estimated. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $4.4 billion through 2014, before insurance recoveries, for its asbestos-related liability.  The Company’s ability to reasonably estimate its liability has been significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for bankruptcy, the inherent uncertainty of future disease incidence and claiming patterns against the Company, the significant expansion of the defendants that are now sued in this litigation, and the continuing changes in the extent to which these defendants participate in the resolution of cases in which the Company is also a defendant.
	The Company has continued to monitor trends that may affect its ultimate liability and has continued to analyze the developments and variables affecting or likely to affect the resolution of pending and future asbestos claims against the Company. The material components of the Company’s accrued liability are based on amounts determined by the Company in connection with its annual comprehensive review and consist of the following estimates, to the extent it is probable that such liabilities have been incurred and can be reasonably estimated: (i) the liability for asbestos claims already asserted against the Company; (ii) the liability for asbestos claims not yet asserted against the Company, but which the Company believes will be asserted in the next several years; and (iii) the legal defense costs likely to be incurred in connection with the claims the Company believes will be asserted in the next several years.
	The significant assumptions underlying the material components of the Company’s accrual relate to:
		a)	the extent to which settlements are limited to claimants who were exposed to the Company’s asbestos-containing insulation prior to its exit from that business in 1958;
		b)	the extent to which claims are resolved under the Company’s administrative claims agreements or on terms comparable to those set forth in those agreements;
		c)	the extent of decrease or increase in the incidence of serious asbestos-related disease cases and claiming patterns against the Company for such cases;
		d)	the extent to which the Company is able to defend itself successfully at trial or on appeal;
		e)	the number and timing of additional co-defendant bankruptcies; and
		f)	the extent to which co-defendants with substantial resources and assets continue to participate significantly in the resolution of future asbestos lawsuits and claims.
	As noted above, the Company conducts a comprehensive review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review.  If the results of an annual comprehensive review indicate that the existing amount of the accrued liability is insufficient to cover its estimated future asbestos-related costs, then the Company will record an appropriate charge to increase the accrued liability.  The Company believes that a reasonable estimation of the probable amount of the liability for claims not yet asserted against the Company is not possible beyond a period of several years.  Therefore, while the results of future annual comprehensive reviews cannot be determined, the Company expects that the addition of one year to the estimation period will usually result in an annual charge.
	The Company’s reported results of operations for 2014 were materially affected by the $135 million fourth quarter charge for asbestos-related costs and asbestos-related payments continue to be substantial.  Any future additional charge would likewise materially affect the Company’s results of operations for the period in which it is recorded. Also, the continued use of significant amounts of cash for asbestos-related costs has affected and may continue to affect the Company’s cost of borrowing and its ability to pursue global or domestic acquisitions. However, the Company believes that its operating cash flows and other sources of liquidity will be sufficient to pay its obligations for asbestos-related costs and to fund its working capital and capital expenditure requirements on a short-term and long-term basis.
	Other Matters
	The Company conducted an internal investigation into conduct in certain of its overseas operations that may have violated the anti-bribery provisions of the United States Foreign Corrupt Practices Act (the “FCPA”), the FCPA’s books and records and internal controls provisions, the Company’s own internal policies, and various local laws.  In October 2012, the Company voluntarily disclosed these matters to the U.S. Department of Justice (the “DOJ”) and the Securities and Exchange Commission (the “SEC”).
	On July 18, 2013, the Company received a letter from the DOJ indicating that it presently did not intend to take any enforcement action and is closing its inquiry into the matter.
	As disclosed in previous periods, the Company is presently unable to predict the duration, scope or result of an investigation by the SEC, if any, or whether the SEC will commence any legal action.  The SEC has a broad range of civil sanctions under the FCPA and other laws and regulations including, but not limited to, injunctive relief, disgorgement, penalties, and modifications to business practices.  The Company could also be subject to investigation and sanctions outside the United States.  While the Company is currently unable to quantify the impact of any potential sanctions or remedial measures, it does not expect such actions will have a material adverse effect on the Company’s liquidity, results of operations or financial condition.
	Other litigation is pending against the Company, in many cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief.  The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated.  Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

Share_Owners_Equity

Share Owners' Equity	3 Months Ended
	Mar. 31, 2015
Share Owners' Equity
Share Owners' Equity
	10.  Share Owners’ Equity
	The activity in share owners’ equity for the three months ended March 31, 2015 and 2014 is as follows:
		Share Owners’ Equity of the Company
		Common			Capital in			Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of			Stock			Earnings			Other			controlling			Owners’
					Par Value									Comprehensive			Interests			Equity
														Loss
	Balance on January 1, 2015	$	2		$	3,066		$	(480	)	$	64		$	(1,494	)	$	117		$	1,275
	Issuance of common stock (32,179 shares)																			—
	Reissuance of common stock (57,459 shares)							2												2
	Treasury shares purchased (3,509,496 shares)							(100		)										(100		)
	Stock compensation				8															8
	Net earnings										71						4			75
	Other comprehensive income (loss)													(216		)	(4		)	(220		)
	Acquisitions of noncontrolling interests				(18		)										6			(12		)
	Balance on March 31, 2015	$	2		$	3,056		$	(578	)	$	135		$	(1,710	)	$	123		$	1,028
		Share Owners’ Equity of the Company
		Common			Capital in			Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of			Stock			Earnings			Other			controlling			Owners’
					Par Value						(Loss)			Comprehensive			Interests			Equity
														Income (Loss)
	Balance on January 1, 2014	$	2		$	3,040		$	(454	)	$	(11	)	$	(1,121	)	$	147		$	1,603
	Issuance of common stock (155,727 shares)				4															4
	Reissuance of common stock (48,041 shares)							2												2
	Stock compensation				8															8
	Net earnings										101						5			106
	Other comprehensive income (loss)													59			(3		)	56
	Distributions to noncontrolling interests																(19		)	(19		)
	Balance on March 31, 2014	$	2		$	3,052		$	(452	)	$	90		$	(1,062	)	$	130		$	1,760
	On February 4, 2015, the Company entered into an accelerated share repurchase agreement (“ASR”) with J.P. Morgan Securities LLC (the “ASR Counterparty”) to repurchase $100 million of its common stock. The Company advanced $100 million to the ASR Counterparty on February 5, 2015, and received 3,509,496 shares, which represented eighty five percent of the total shares as calculated using the closing price on February 4, 2015.  The remaining number of shares to be delivered will be based on the daily volume-weighted average price of the Company’s common stock during the term of the ASR. The ASR is expected to be settled in the second quarter of this year.  Under the terms of the ASR program, the ASR Counterparty was permitted, in accordance with the applicable requirements of the federal securities laws, to separately trade in the Company’s shares.
	The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:
		Shares Outstanding (in thousands)
		March 31,		December 31,		March 31,
		2015		2014		2014
	Shares of common stock issued (including treasury shares)	184,421		183,915		183,811
	Treasury shares	23,170		19,718		18,738

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2015
Accumulated Other Comprehensive Loss.
Accumulated Other Comprehensive Loss
	11. Accumulated Other Comprehensive Loss
	The activity in accumulated other comprehensive loss for the three months ended March 31, 2015 and 2014 is as follows:
			Net Effect of			Change in			Employee Benefit			Total
			Exchange Rate			Certain Derivative			Plans			Accumulated
			Fluctuations			Instruments						Other
												Comprehensive
												Loss
	Balance on January 1, 2015		$	(55	)	$	(11	)	$	(1,428	)	$	(1,494	)
	Change before reclassifications		(253		)							(253		)
	Amounts reclassified from accumulated other comprehensive income								21		(b)	21
	Translation effect								15			15
	Tax effect								1			1
	Other comprehensive income attributable to the Company		(253		)	—			37			(216		)
	Balance on March 31, 2015		$	(308	)	$	(11	)	$	(1,391	)	$	(1,710	)
			Net Effect of			Change in			Employee Benefit			Total
			Exchange Rate			Certain Derivative			Plans			Accumulated
			Fluctuations			Instruments						Other
												Comprehensive
												Loss
	Balance on January 1, 2014		$	229		$	(12	)	$	(1,338	)	$	(1,121	)
	Change before reclassifications		35			2						37
	Amounts reclassified from accumulated other comprehensive income					(1		)(a)	23		(b)	22
	Translation effect								1			1
	Tax effect								(1		)	(1		)
	Other comprehensive income attributable to the Company		35			1			23			59
	Balance on March 31, 2014		$	264		$	(11	)	$	(1,315	)	$	(1,062	)
		(a)		Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information).
		(b)		Amount is included in the computation of net postretirement benefit cost and net periodic pension cost (see Note 6 for additional information).

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share
Earnings Per Share	12. Earnings Per Share
	The following table sets forth the computation of basic and diluted earnings per share:
		Three months ended March 31,
		2015		2014
	Numerator:
	Net earnings attributable to the Company	$	71	$	101
	Denominator (in thousands):
	Denominator for basic earnings per share - weighted average shares outstanding	162,146		164,760
	Effect of dilutive securities:
	Stock options and other	1,141		1,405
	Denominator for diluted earnings per share - adjusted weighted average shares outstanding	163,287		166,165
	Basic earnings per share:
	Earnings from continuing operations	$	0.44	$	0.62
	Loss from discontinued operations			(0.01		)
	Net earnings	$	0.44	$	0.61
	Diluted earnings per share:
	Earnings from continuing operations	$	0.44	$	0.62
	Loss from discontinued operations			(0.01		)
	Net earnings	$	0.44	$	0.61
	Options to purchase 1,798,933 and 370,012 weighted average shares of common stock which were outstanding during the three months ended March 31, 2015 and 2014, respectively, were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares.

Supplemental_Cash_Flow_Informa

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2015
Supplemental Cash Flow Information
Supplemental Cash Flow Information	13. Supplemental Cash Flow Information
		Three months ended March 31,
		2015		2014
	Interest paid in cash	$	59	$	70
	Income taxes paid in cash (non-U.S.)	$	32	$	31

Discontinued_Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2015
Discontinued Operations
Discontinued Operations	14.  Discontinued Operations
	On March 10, 2015, a tribunal constituted under the auspices of the International Centre for Settlement of Investment Disputes (ICSID) awarded a subsidiary of the Company more than $455 million in an international arbitration against Venezuela related to the 2010 expropriation of the Company’s majority interest in two plants in that country.  Subsequently, Venezuela has announced that it has started the process of filing for an annulment of this award.  The annulment process can take up to several years to complete.  The Company is unable at this stage to predict the amount, or timing of compensation it will ultimately receive under the award. Therefore, the Company has not recognized this award in its financial statements.
	A separate arbitration is pending with ICSID to obtain compensation primarily for third-party minority shareholders’ lost interests in the two expropriated plants.
	The loss from discontinued operations of $1 million for the three months ended March 31, 2014 is related to ongoing costs for the 2010 Venezuela expropriation.  The loss from discontinued operations was less than $1 million for the three months ended March 31, 2015 and also related to ongoing costs for the Venezuela expropriation.

New_Accounting_Pronouncement

New Accounting Pronouncement	3 Months Ended
	Mar. 31, 2015
New Accounting Pronouncement
New Accounting Pronouncement	15. New Accounting Pronouncement
	Revenue from Contracts with Customers
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers”, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The new standard is effective for the Company on January 1, 2017. Early application is not permitted. The Company is currently evaluating the effect this standard will have on its consolidated financial statements and related disclosures.  The Company has not yet selected a transition method nor determined the effect of the standard on its ongoing financial reporting.
	On April 1, 2015, the FASB proposed deferring the effective date by one year to December 15, 2017 for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016.
	Presentation of Debt Issuance Costs
	In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for the Company on January 1, 2016, but early adoption is permitted. The Company is currently evaluating the impact the adoption of this standard will have on the Company’s consolidated financial statements.

Financial_Information_for_Subs

Financial Information for Subsidiary Guarantors and Non-Guarantors	3 Months Ended
	Mar. 31, 2015
Financial Information for Subsidiary Guarantors and Non-Guarantors
Financial Information for Subsidiary Guarantors and Non-Guarantors	16.  Financial Information for Subsidiary Guarantors and Non-Guarantors
	The following presents condensed consolidating financial information for the Company, segregating:  (1) Owens-Illinois, Inc., the issuer of senior debentures (the “Parent”); (2) the two subsidiaries which have guaranteed the senior debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other subsidiaries (the “Non-Guarantor Subsidiaries”).  The Guarantor Subsidiaries are 100% owned direct and indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several.  They have no operations and function only as intermediate holding companies.
	Certain reclassifications have been made to conform all of the financial information to the financial presentation on a consolidated basis.  The principal eliminations relate to investments in subsidiaries and intercompany balances and transactions.
		March 31, 2015
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	257		$	—		$	257
	Receivables							861						861
	Inventories							1,007						1,007
	Other current assets							74						74
	Total current assets	—			—			2,199			—			2,199
	Investments in and advances to subsidiaries	1,583			1,326						(2,909		)	—
	Property, plant and equipment, net							2,337						2,337
	Goodwill							1,752						1,752
	Other assets							1,038						1,038
	Total assets	$	1,583		$	1,326		$	7,326		$	(2,909	)	$	7,326
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—		$	637		$	—		$	637
	Current portion of asbestos liability	143												143
	Accounts payable							919						919
	Other liabilities	7						417			(7		)	417
	Total current liabilities	150			—			1,973			(7		)	2,116
	Long-term debt	250						2,984			(250		)	2,984
	Asbestos-related liabilities	278												278
	Other long-term liabilities							920						920
	Share owners’ equity	905			1,326			1,326			(2,652		)	905
	Noncontrolling interest							123						123
	Total liabilities and share owners’ equity	$	1,583		$	1,326		$	7,326		$	(2,909	)	$	7,326
		December 31, 2014
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	512		$	—		$	512
	Receivables							744						744
	Inventories							1,035						1,035
	Other current assets							80						80
	Total current assets	—			—			2,371			—			2,371
	Investments in and advances to subsidiaries	1,863			1,593						(3,456		)	—
	Property, plant and equipment, net							2,445						2,445
	Goodwill							1,893						1,893
	Other assets							1,149						1,149
	Total assets	$	1,863		$	1,593		$	7,858		$	(3,456	)	$	7,858
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—		$	488		$	—		$	488
	Current portion of asbestos liability	143												143
	Accounts payable							1,137						1,137
	Other liabilities	20						560			(20		)	560
	Total current liabilities	163			—			2,185			(20		)	2,328
	Long-term debt	250						2,972			(250		)	2,972
	Asbestos-related liabilities	292												292
	Other long-term liabilities							991						991
	Share owners’ equity	1,158			1,593			1,593			(3,186		)	1,158
	Noncontrollling interest							117						117
	Total liabilities and share owners’ equity	$	1,863		$	1,593		$	7,858		$	(3,456	)	$	7,858
		March 31, 2014
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	201		$	—		$	201
	Receivables							1,078						1,078
Inventories							1,204						1,204
Other current assets							94						94
Total current assets	—			—			2,577			—			2,577
Investments in and advances to subsidiaries	2,313			2,063						(4,376		)	—
Property, plant and equipment, net							2,634						2,634
Goodwill							2,059						2,059
Other assets							1,218						1,218
Total assets	$	2,313		$	2,063		$	8,488		$	(4,376	)	$	8,488
Current liabilities:
Short-term loans and long-term debt due within one year	$	—		$	—		$	331		$	—		$	331
Current portion of asbestos liability	150												150
Accounts payable							1,074						1,074
Other liabilities							527						527
Total current liabilities	150			—			1,932			—			2,082
Long-term debt	250						3,371			(250		)	3,371
Asbestos-related liabilities	283												283
Other long-term liabilities							992						992
Share owners’ equity	1,630			2,063			2,063			(4,126		)	1,630
Noncontrolling interest							130						130
Total liabilities and share owners’ equity	$	2,313		$	2,063		$	8,488		$	(4,376	)	$	8,488
	Three months ended March 31, 2015
							Non-
				Guarantor			Guarantor
Results of Operations	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Net sales							$	1,421					$	1,421
Cost of goods sold							(1,153		)				(1,153		)
Gross profit	—			—			268			—			268
Selling and administrative expense							(124		)				(124		)
Research, development and engineering expense							(15		)				(15		)
Net intercompany interest	7						(7		)				—
Interest expense, net	(7		)				(40		)				(47		)
Equity earnings from subsidiaries	71			71						(142		)	—
Other equity earnings							15						15
Other expense, net							3						3
Earnings before income taxes	71			71			100			(142		)	100
Provision for income taxes							(25		)				(25		)
Earnings from continuing operations	71			71			75			(142		)	75
Loss from discontinued operations													—
Net earnings	71			71			75			(142		)	75
Net earnings attributable to noncontrolling interests							(4		)				(4		)
Net earnings attributable to the Company	$	71		$	71		$	71		$	(142	)	$	71
	Three months ended March 31, 2015
							Non-
				Guarantor			Guarantor
Comprehensive Income	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Net earnings	$	71		$	71		$	75		$	(142	)	$	75
Other comprehensive income, net	(216		)	(216		)	(220		)	432			(220		)
Total comprehensive income	(145		)	(145		)	(145		)	290			(145		)
Comprehensive income attributable to noncontrolling interests													—
Comprehensive income attributable to the Company	$	(145	)	$	(145	)	$	(145	)	$	290		$	(145	)
	Three months ended March 31, 2014
							Non-
				Guarantor			Guarantor
Results of Operations	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Net sales	$	—		$	—		$	1,639		$	—		$	1,639
Cost of goods sold							(1,318		)				(1,318		)
Gross profit	—			—			321			—			321
Selling and administrative expense							(133		)				(133		)
Research, development and engineering expense							(15		)				(15		)
Net intercompany interest	5						(5		)				—
Interest expense, net	(5		)				(49		)				(54		)
Equity earnings from subsidiaries	101			101						(202		)	—
Other equity earnings							16						16
Other expense, net							(1		)				(1		)
Earnings before income taxes	101			101			134			(202		)	134
Provision for income taxes							(27		)				(27		)
Earnings from continuing operations	101			101			107			(202		)	107
Loss from discontinued operations							(1		)				(1		)
Net earnings	101			101			106			(202		)	106
Net earnings attributable to noncontrolling interests							(5		)				(5		)
Net earnings attributable to the Company	$	101		$	101		$	101		$	(202	)	$	101
	Three months ended March 31, 2014
							Non-
				Guarantor			Guarantor
Comprehensive Income	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Net earnings	$	101		$	101		$	106		$	(202	)	$	106
Other comprehensive income, net	59			59			56			(118		)	56
Total comprehensive income	160			160			162			(320		)	162
Comprehensive income attributable to noncontrolling interests							(2		)				(2		)
Comprehensive income attributable to the Company	$	160		$	160		$	160		$	(320	)	$	160
	Three months ended March 31, 2015
							Non-
				Guarantor			Guarantor
Cash Flows	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Cash utilized in operating activities	$	(15	)	$	—		$	(263	)	$	—		$	(278	)
Cash utilized in investing activities							(157		)				(157		)
Cash provided by financing activities	15						192						207
Effect of exchange rate change on cash							(27		)				(27		)
Net change in cash	—			—			(255		)	—			(255		)
Cash at beginning of period							512						512
Cash at end of period	$	—		$	—		$	257		$	—		$	257
	Three months ended March 31, 2014
							Non-
				Guarantor			Guarantor
Cash Flows	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Cash utilized in operating activities	$	(15	)	$	—		$	(188	)	$	—		$	(203	)
Cash utilized in investing activities							(94		)				(94		)
Cash provided by financing activities	15						106						121
Effect of exchange rate change on cash							(6		)				(6		)
Net change in cash	—			—			(182		)	—			(182		)
Cash at beginning of period							383						383
Cash at end of period	$	—		$	—		$	201		$	—		$	201

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Information
Net sales for the Company's reportable segments
		2015			2014
	Net sales:
	Europe	$	567		$	706
	North America	470			485
	South America	205			239
	Asia Pacific	163			203
	Reportable segment totals	1,405			1,633
	Other	16			6
	Net sales	$	1,421		$	1,639
Segment operating profit (loss) for the Company's reportable segments
		2015			2014
	Segment operating profit:
	Europe	$	49		$	87
	North America	71			65
	South America	30			41
	Asia Pacific	18			25
	Reportable segment totals	168			218
	Items excluded from segment operating profit:
	Retained corporate costs and other	(21		)	(30		)
	Interest expense, net	(47		)	(54		)
	Earnings from continuing operations before income taxes	$	100		$	134
Total assets for the Company's reportable segments
		March 31,			December 31,			March 31,
		2015			2014			2014
	Total assets:
	Europe	$	2,935		$	3,223		$	3,585
	North America	2,033			1,971			2,055
	South America	1,097			1,300			1,453
	Asia Pacific	942			1,018			1,142
	Reportable segment totals	7,007			7,512			8,235
	Other	319			346			253
	Consolidated totals	$	7,326		$	7,858		$	8,488

Receivables_Tables

Receivables (Tables)	3 Months Ended
	Mar. 31, 2015
Receivables
Schedule of receivables
		March 31,		December 31,		March 31,
		2015		2014		2014
	Trade accounts receivable	$	697	$	583	$	911
	Less: allowances for doubtful accounts and discounts	31		34		39
	Net trade receivables	666		549		872
	Other receivables	195		195		206
		$	861	$	744	$	1,078

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2015
Inventories
Major classes of inventory
		March 31,		December 31,		March 31,
		2015		2014		2014
	Finished goods	$	858	$	884	$	1,037
	Raw materials	109		110		121
	Operating supplies	40		41		46
		$	1,007	$	1,035	$	1,204

Derivative_Instruments_Tables

Derivative Instruments (Tables)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments
Effect of commodity futures contracts designated as cash flow hedges on the results of operations
							Amount of Gain
	Amount of Gain						Reclassified from
	Recognized in OCI on						Accumulated OCI into Income
	Commodity Forward Contracts						(reported in Cost of goods sold)
	(Effective Portion)						(Effective Portion)
	2015			2014			2015			2014
	$	—		$	2		$	—		$	1
Effect of the forward exchange contracts not designated as hedging instruments on the results of operations
			Amount of Gain (Loss)
	Location of Gain (Loss)		Recognized in Income on
	Recognized in Income on		Forward Exchange Contracts
	Forward Exchange Contracts		2015			2014
	Other expense, net		$	11		$	(1	)
Balance Sheet Classification of derivative instruments
			Balance		Fair Value
			Sheet		March 31,			December 31,			March 31,
			Location		2015			2014			2014
	Asset Derivatives:
	Derivatives designated as hedging instruments:
	Commodity forward contracts		a		$	—		$	—		$	2
	Derivatives not designated as hedging instruments:
	Foreign exchange derivative contracts		a		21			10			4
	Foreign exchange derivative contracts		c								3
	Total derivatives not designated as hedging instruments				21			10			7
	Total asset derivatives				$	21		$	10		$	9
	Liability Derivatives:
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		c		$	2		$	4		$	10
	Total liability derivatives				$	2		$	4		$	10

Restructuring_Accruals_Tables

Restructuring Accruals (Tables)	3 Months Ended
	Mar. 31, 2015
Restructuring Accruals
Selected information related to the restructuring accruals
		European			Asia Pacific			Other			Total
		Asset			Restructuring			Restructuring			Restructuring
		Optimization						Actions
	Balance at January 1, 2015	$	12		$	12		$	36		$	60
	Net cash paid, principally severance and related benefits				(1		)	(9		)	(10		)
	Other, including foreign exchange translation	(1		)	(1		)	(2		)	(4		)
	Balance at March 31, 2015	$	11		$	10		$	25		$	46
	Balance at January 1, 2014	$	30		$	20		$	64		$	114
	Net cash paid, principally severance and related benefits	(2		)	(4		)	(15		)	(21		)
	Other, including foreign exchange translation	(1		)	(4		)	(3		)	(8		)
	Balance at March 31, 2014	$	27		$	12		$	46		$	85

Pension_Benefit_Plans_Tables

Pension Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2015
Pension Benefit Plans.
Components of net periodic pension cost
		U.S.						Non-U.S.
		2015			2014			2015			2014
	Service cost	$	6		$	6		$	4		$	7
	Interest cost	24			27			12			18
	Expected asset return	(42		)	(43		)	(21		)	(22		)
	Amortization:
	Actuarial loss	19			18			5			4
	Net periodic pension cost	$	7		$	8		$	—		$	7

Debt_Tables

Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Debt
Long-term Debt
		March 31,			December 31,			March 31,
		2015			2014			2014
	Secured Credit Agreement:
	Revolving Credit Facility:
	Revolving Loans	$	264		$	—		$	150
	Term Loans:
	Term Loan B	390			405			405
	Term Loan C (76 million CAD at March 31, 2015)	59			70			74
	Term Loan D (€85 million at March 31, 2015)	91			103			116
	Senior Notes:
	3.00%, Exchangeable, due 2015	18			18			621
	7.375%, due 2016	597			596			594
	6.75%, due 2020 (€500 million)	539			608			688
	4.875%, due 2021 (€330 million)	356			401			454
	5.00%, due 2022	494			494
	5.375%, due 2025	296			296
	Senior Debentures:
	7.80%, due 2018	250			250			250
	Capital Leases	66			63			38
	Other	24			29			22
	Total long-term debt	3,444			3,333			3,412
	Less amounts due within one year	460			361			41
	Long-term debt	$	2,984		$	2,972		$	3,371
Information related to accounts receivable securitization program
		March 31,			December 31,			March 31,
		2015			2014			2014
	Balance (included in short-term loans)	$	171		$	122		$	253
	Weighted average interest rate	1.36		%	1.41		%	1.53		%
Fair values of the Company's significant fixed rate debt obligations
					Indicated
		Principal			Market		Fair
		Amount			Price		Value
	Senior Notes:
	7.375%, due 2016	$	600		105.88		$	635
	6.75%, due 2020 (€500 million)	539			120.91		652
	4.875%, due 2021 (€330 million)	356			112.33		400
	5.00%, due 2022	500			102.63		513
	5.375%, due 2025	300			103.13		309
	Senior Debentures:
	7.80%, due 2018	250			112.56		281

Share_Owners_Equity_Tables

Share Owners' Equity (Tables)	3 Months Ended
	Mar. 31, 2015
Share Owners' Equity
Activity in share owners' equity
		Share Owners’ Equity of the Company
		Common			Capital in			Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of			Stock			Earnings			Other			controlling			Owners’
					Par Value									Comprehensive			Interests			Equity
														Loss
	Balance on January 1, 2015	$	2		$	3,066		$	(480	)	$	64		$	(1,494	)	$	117		$	1,275
	Issuance of common stock (32,179 shares)																			—
	Reissuance of common stock (57,459 shares)							2												2
	Treasury shares purchased (3,509,496 shares)							(100		)										(100		)
	Stock compensation				8															8
	Net earnings										71						4			75
	Other comprehensive income (loss)													(216		)	(4		)	(220		)
	Acquisitions of noncontrolling interests				(18		)										6			(12		)
	Balance on March 31, 2015	$	2		$	3,056		$	(578	)	$	135		$	(1,710	)	$	123		$	1,028
		Share Owners’ Equity of the Company
		Common			Capital in			Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of			Stock			Earnings			Other			controlling			Owners’
					Par Value						(Loss)			Comprehensive			Interests			Equity
														Income (Loss)
	Balance on January 1, 2014	$	2		$	3,040		$	(454	)	$	(11	)	$	(1,121	)	$	147		$	1,603
	Issuance of common stock (155,727 shares)				4															4
	Reissuance of common stock (48,041 shares)							2												2
	Stock compensation				8															8
	Net earnings										101						5			106
	Other comprehensive income (loss)													59			(3		)	56
	Distributions to noncontrolling interests																(19		)	(19		)
	Balance on March 31, 2014	$	2		$	3,052		$	(452	)	$	90		$	(1,062	)	$	130		$	1,760
Schedule of shares outstanding
		Shares Outstanding (in thousands)
		March 31,		December 31,		March 31,
		2015		2014		2014
	Shares of common stock issued (including treasury shares)	184,421		183,915		183,811
	Treasury shares	23,170		19,718		18,738

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2015
Accumulated Other Comprehensive Loss.
Component of accumulated other comprehensive loss
			Net Effect of			Change in			Employee Benefit			Total
			Exchange Rate			Certain Derivative			Plans			Accumulated
			Fluctuations			Instruments						Other
												Comprehensive
												Loss
	Balance on January 1, 2015		$	(55	)	$	(11	)	$	(1,428	)	$	(1,494	)
	Change before reclassifications		(253		)							(253		)
	Amounts reclassified from accumulated other comprehensive income								21		(b)	21
	Translation effect								15			15
	Tax effect								1			1
	Other comprehensive income attributable to the Company		(253		)	—			37			(216		)
	Balance on March 31, 2015		$	(308	)	$	(11	)	$	(1,391	)	$	(1,710	)
			Net Effect of			Change in			Employee Benefit			Total
			Exchange Rate			Certain Derivative			Plans			Accumulated
			Fluctuations			Instruments						Other
												Comprehensive
												Loss
	Balance on January 1, 2014		$	229		$	(12	)	$	(1,338	)	$	(1,121	)
	Change before reclassifications		35			2						37
	Amounts reclassified from accumulated other comprehensive income					(1		)(a)	23		(b)	22
	Translation effect								1			1
	Tax effect								(1		)	(1		)
	Other comprehensive income attributable to the Company		35			1			23			59
	Balance on March 31, 2014		$	264		$	(11	)	$	(1,315	)	$	(1,062	)
		(a)		Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information).
		(b)		Amount is included in the computation of net postretirement benefit cost and net periodic pension cost (see Note 6 for additional information).

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share
Computation of basic and diluted earnings per share
		Three months ended March 31,
		2015		2014
	Numerator:
	Net earnings attributable to the Company	$	71	$	101
	Denominator (in thousands):
	Denominator for basic earnings per share - weighted average shares outstanding	162,146		164,760
	Effect of dilutive securities:
	Stock options and other	1,141		1,405
	Denominator for diluted earnings per share - adjusted weighted average shares outstanding	163,287		166,165
	Basic earnings per share:
	Earnings from continuing operations	$	0.44	$	0.62
	Loss from discontinued operations			(0.01		)
	Net earnings	$	0.44	$	0.61
	Diluted earnings per share:
	Earnings from continuing operations	$	0.44	$	0.62
	Loss from discontinued operations			(0.01		)
	Net earnings	$	0.44	$	0.61

Supplemental_Cash_Flow_Informa1

Supplemental Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2015
Supplemental Cash Flow Information
Income taxes paid (received) in cash
		Three months ended March 31,
		2015		2014
	Interest paid in cash	$	59	$	70
	Income taxes paid in cash (non-U.S.)	$	32	$	31

Financial_Information_for_Subs1

Financial Information for Subsidiary Guarantors and Non-Guarantors (Tables)	3 Months Ended
	Mar. 31, 2015
Financial Information for Subsidiary Guarantors and Non-Guarantors
Balance Sheet
		March 31, 2015
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	257		$	—		$	257
	Receivables							861						861
	Inventories							1,007						1,007
	Other current assets							74						74
	Total current assets	—			—			2,199			—			2,199
	Investments in and advances to subsidiaries	1,583			1,326						(2,909		)	—
	Property, plant and equipment, net							2,337						2,337
	Goodwill							1,752						1,752
	Other assets							1,038						1,038
	Total assets	$	1,583		$	1,326		$	7,326		$	(2,909	)	$	7,326
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—		$	637		$	—		$	637
	Current portion of asbestos liability	143												143
	Accounts payable							919						919
	Other liabilities	7						417			(7		)	417
	Total current liabilities	150			—			1,973			(7		)	2,116
	Long-term debt	250						2,984			(250		)	2,984
	Asbestos-related liabilities	278												278
	Other long-term liabilities							920						920
	Share owners’ equity	905			1,326			1,326			(2,652		)	905
	Noncontrolling interest							123						123
	Total liabilities and share owners’ equity	$	1,583		$	1,326		$	7,326		$	(2,909	)	$	7,326
		December 31, 2014
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	512		$	—		$	512
	Receivables							744						744
	Inventories							1,035						1,035
	Other current assets							80						80
	Total current assets	—			—			2,371			—			2,371
	Investments in and advances to subsidiaries	1,863			1,593						(3,456		)	—
	Property, plant and equipment, net							2,445						2,445
	Goodwill							1,893						1,893
	Other assets							1,149						1,149
	Total assets	$	1,863		$	1,593		$	7,858		$	(3,456	)	$	7,858
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—		$	488		$	—		$	488
	Current portion of asbestos liability	143												143
	Accounts payable							1,137						1,137
	Other liabilities	20						560			(20		)	560
	Total current liabilities	163			—			2,185			(20		)	2,328
	Long-term debt	250						2,972			(250		)	2,972
	Asbestos-related liabilities	292												292
	Other long-term liabilities							991						991
	Share owners’ equity	1,158			1,593			1,593			(3,186		)	1,158
	Noncontrollling interest							117						117
	Total liabilities and share owners’ equity	$	1,863		$	1,593		$	7,858		$	(3,456	)	$	7,858
		March 31, 2014
								Non-
					Guarantor			Guarantor
	Balance Sheet	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	201		$	—		$	201
	Receivables							1,078						1,078
	Inventories							1,204						1,204
	Other current assets							94						94
Total current assets	—			—			2,577			—			2,577
Investments in and advances to subsidiaries	2,313			2,063						(4,376		)	—
Property, plant and equipment, net							2,634						2,634
Goodwill							2,059						2,059
Other assets							1,218						1,218
Total assets	$	2,313		$	2,063		$	8,488		$	(4,376	)	$	8,488
Current liabilities:
Short-term loans and long-term debt due within one year	$	—		$	—		$	331		$	—		$	331
Current portion of asbestos liability	150												150
Accounts payable							1,074						1,074
Other liabilities							527						527
Total current liabilities	150			—			1,932			—			2,082
Long-term debt	250						3,371			(250		)	3,371
Asbestos-related liabilities	283												283
Other long-term liabilities							992						992
Share owners’ equity	1,630			2,063			2,063			(4,126		)	1,630
Noncontrolling interest							130						130
Total liabilities and share owners’ equity	$	2,313		$	2,063		$	8,488		$	(4,376	)	$	8,488
Results of Operations and Comprehensive Income
		Three months ended March 31, 2015
								Non-
					Guarantor			Guarantor
	Results of Operations	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Net sales							$	1,421					$	1,421
	Cost of goods sold							(1,153		)				(1,153		)
	Gross profit	—			—			268			—			268
	Selling and administrative expense							(124		)				(124		)
	Research, development and engineering expense							(15		)				(15		)
	Net intercompany interest	7						(7		)				—
	Interest expense, net	(7		)				(40		)				(47		)
	Equity earnings from subsidiaries	71			71						(142		)	—
	Other equity earnings							15						15
	Other expense, net							3						3
	Earnings before income taxes	71			71			100			(142		)	100
	Provision for income taxes							(25		)				(25		)
	Earnings from continuing operations	71			71			75			(142		)	75
	Loss from discontinued operations													—
	Net earnings	71			71			75			(142		)	75
	Net earnings attributable to noncontrolling interests							(4		)				(4		)
	Net earnings attributable to the Company	$	71		$	71		$	71		$	(142	)	$	71
		Three months ended March 31, 2015
								Non-
					Guarantor			Guarantor
	Comprehensive Income	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Net earnings	$	71		$	71		$	75		$	(142	)	$	75
	Other comprehensive income, net	(216		)	(216		)	(220		)	432			(220		)
	Total comprehensive income	(145		)	(145		)	(145		)	290			(145		)
	Comprehensive income attributable to noncontrolling interests													—
	Comprehensive income attributable to the Company	$	(145	)	$	(145	)	$	(145	)	$	290		$	(145	)
		Three months ended March 31, 2014
								Non-
					Guarantor			Guarantor
	Results of Operations	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Net sales	$	—		$	—		$	1,639		$	—		$	1,639
	Cost of goods sold							(1,318		)				(1,318		)
	Gross profit	—			—			321			—			321
	Selling and administrative expense							(133		)				(133		)
	Research, development and engineering expense							(15		)				(15		)
	Net intercompany interest	5						(5		)				—
	Interest expense, net	(5		)				(49		)				(54		)
	Equity earnings from subsidiaries	101			101						(202		)	—
	Other equity earnings							16						16
	Other expense, net							(1		)				(1		)
	Earnings before income taxes	101			101			134			(202		)	134
	Provision for income taxes							(27		)				(27		)
	Earnings from continuing operations	101			101			107			(202		)	107
	Loss from discontinued operations							(1		)				(1		)
	Net earnings	101			101			106			(202		)	106
	Net earnings attributable to noncontrolling interests							(5		)				(5		)
	Net earnings attributable to the Company	$	101		$	101		$	101		$	(202	)	$	101
		Three months ended March 31, 2014
								Non-
					Guarantor			Guarantor
	Comprehensive Income	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Net earnings	$	101		$	101		$	106		$	(202	)	$	106
	Other comprehensive income, net	59			59			56			(118		)	56
	Total comprehensive income	160			160			162			(320		)	162
	Comprehensive income attributable to noncontrolling interests							(2		)				(2		)
	Comprehensive income attributable to the Company	$	160		$	160		$	160		$	(320	)	$	160
Cash Flows
		Three months ended March 31, 2015
								Non-
					Guarantor			Guarantor
	Cash Flows	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Cash utilized in operating activities	$	(15	)	$	—		$	(263	)	$	—		$	(278	)
	Cash utilized in investing activities							(157		)				(157		)
	Cash provided by financing activities	15						192						207
	Effect of exchange rate change on cash							(27		)				(27		)
	Net change in cash	—			—			(255		)	—			(255		)
	Cash at beginning of period							512						512
	Cash at end of period	$	—		$	—		$	257		$	—		$	257
		Three months ended March 31, 2014
								Non-
					Guarantor			Guarantor
	Cash Flows	Parent			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Cash utilized in operating activities	$	(15	)	$	—		$	(188	)	$	—		$	(203	)
	Cash utilized in investing activities							(94		)				(94		)
	Cash provided by financing activities	15						106						121
	Effect of exchange rate change on cash							(6		)				(6		)
	Net change in cash	—			—			(182		)	—			(182		)
	Cash at beginning of period							383						383
	Cash at end of period	$	—		$	—		$	201		$	—		$	201

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
	item
Segment Reporting Information
Number of reportable segments	4
Net sales:
Net sales	$1,421	$1,639
Items excluded from Segment Operating Profit:
Retained corporate costs and other	-21	-30
Interest expense, net	-47	-54
Earnings from continuing operations before income taxes	100	134
Reportable Segment Totals
Net sales:
Net sales	1,405	1,633
Segment Operating Profit:
Segment Operating Profit	168	218
Europe
Net sales:
Net sales	567	706
Segment Operating Profit:
Segment Operating Profit	49	87
North America
Net sales:
Net sales	470	485
Segment Operating Profit:
Segment Operating Profit	71	65
South America
Net sales:
Net sales	205	239
Segment Operating Profit:
Segment Operating Profit	30	41
Asia Pacific
Net sales:
Net sales	163	203
Segment Operating Profit:
Segment Operating Profit	18	25
Other
Net sales:
Net sales	$16	$6

Segment_Information_Details_2

Segment Information (Details 2) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Assets
Total assets:	$7,326	$7,858	$8,488
Reportable Segment Totals
Assets
Total assets:	7,007	7,512	8,235
Europe
Assets
Total assets:	2,935	3,223	3,585
North America
Assets
Total assets:	2,033	1,971	2,055
South America
Assets
Total assets:	1,097	1,300	1,453
Asia Pacific
Assets
Total assets:	942	1,018	1,142
Other
Assets
Total assets:	$319	$346	$253

Receivables_Details

Receivables (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Receivables
Trade accounts receivable	$697	$583	$911
Less: allowances for doubtful accounts and discounts	31	34	39
Net trade receivables	666	549	872
Other receivables	195	195	206
Total	861	744	1,078
Amount of receivables sold	$219	$276	$151

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Inventories
Finished goods	$858	$884	$1,037
Raw materials	109	110	121
Operating supplies	40	41	46
Inventories	$1,007	$1,035	$1,204

Derivative_Instruments_Details

Derivative Instruments (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Commodity forward contracts | Cash Flow Hedges
Derivatives and Hedges
Coverage of commodity futures contracts (in MM BTUs)	5,400,000	4,400,000
Unrecognized (loss) gain included in Accumulated OCI		$2
Commodity futures contracts gain (loss) recognized in OCI		2
Commodity futures contracts loss reclassified from accumulated OCI into income		1
Commodity forward contracts | Cash Flow Hedges | Minimum
Derivatives and Hedges
Period during which unrecognized loss included in Accumulated OCI will be reclassified into earnings	12 months
Commodity forward contracts | Cash Flow Hedges | Maximum
Derivatives and Hedges
Period during which unrecognized loss included in Accumulated OCI will be reclassified into earnings	24 months
Foreign exchange contracts | Derivatives not designated as hedging instruments
Derivatives and Hedges
Forward exchange contracts in various currencies	532	670
Forward exchange contracts gain (loss) recognized in income	$11	($1)

Derivative_Instruments_Details1

Derivative Instruments (Details 2) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified
Derivatives, Fair Value
Total asset derivatives	$21	$10	$9
Total liability derivatives	2	4	10
Derivatives designated as hedging instruments | Commodity forward contracts | Receivables.
Derivatives, Fair Value
Total asset derivatives			2
Derivatives not designated as hedging instruments
Derivatives, Fair Value
Total asset derivatives	21	10	7
Derivatives not designated as hedging instruments | Foreign exchange contracts | Receivables.
Derivatives, Fair Value
Total asset derivatives	21	10	4
Derivatives not designated as hedging instruments | Foreign exchange contracts | Other liabilities (current)
Derivatives, Fair Value
Total asset derivatives			3
Total liability derivatives	$2	$4	$10

Restructuring_Accruals_Details

Restructuring Accruals (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Restructuring accrual
Restructuring reserve balance at beginning of period	$60	$114
Net cash paid, principally severance and related benefits	-10	-21
Other, including foreign exchange translation	-4	-8
Restructuring reserve balance at end of period	46	85
European Asset Optimization
Restructuring accrual
Restructuring reserve balance at beginning of period	12	30
Net cash paid, principally severance and related benefits		-2
Other, including foreign exchange translation	-1	-1
Restructuring reserve balance at end of period	11	27
Asia Pacific Restructuring
Restructuring accrual
Restructuring reserve balance at beginning of period	12	20
Net cash paid, principally severance and related benefits	-1	-4
Other, including foreign exchange translation	-1	-4
Restructuring reserve balance at end of period	10	12
Other Restructuring Actions
Restructuring accrual
Restructuring reserve balance at beginning of period	36	64
Net cash paid, principally severance and related benefits	-9	-15
Other, including foreign exchange translation	-2	-3
Restructuring reserve balance at end of period	$25	$46

Pension_Benefit_Plans_Details

Pension Benefit Plans (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
U.S Pension Plans
Components of the net pension expense and postretirement benefit cost
Service cost	$6	$6
Interest cost	24	27
Expected asset return	-42	-43
Amortization:
Actuarial loss	19	18
Net periodic pension cost	7	8
Non-U.S. Pension Plans
Components of the net pension expense and postretirement benefit cost
Service cost	4	7
Interest cost	12	18
Expected asset return	-21	-22
Amortization:
Actuarial loss	5	4
Net periodic pension cost		$7

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Income Taxes
Statutory U.S. Federal tax rate (as a percent)	35.00%
Period of cumulative income position of the operations	3 years
Valuation allowance		$927

Debt_Details

Debt (Details)

3 Months Ended

0 Months Ended

3 Months Ended

1 Months Ended

0 Months Ended

0 Months Ended

In Millions, except Per Share data, unless otherwise specified

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Mar. 31, 2015

Apr. 22, 2015

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Apr. 22, 2015

Apr. 22, 2015

Apr. 22, 2015

Mar. 31, 2015

Apr. 22, 2015

Apr. 22, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2014

Mar. 31, 2015

Apr. 22, 2015

Apr. 22, 2015

Apr. 22, 2015

Apr. 22, 2015

USD ($)

USD ($)

USD ($)

Prior Senior Credit Agreement

New Senior Credit Agreement

Parent

Parent

Parent

Secured Credit Agreement

Revolving Loans

Revolving Loans

Term Loan B

Term Loan B

Term Loan B

Term Loan C (76 million CAD at March 31, 2015)

Term Loan C (76 million CAD at March 31, 2015)

Term Loan C (76 million CAD at March 31, 2015)

Term Loan C (76 million CAD at March 31, 2015)

Term Loan D (EUR 85 million at March 31, 2015)

Term Loan D (EUR 85 million at March 31, 2015)

Term Loan D (EUR 85 million at March 31, 2015)

Term Loan D (EUR 85 million at March 31, 2015)

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 7.375%, due 2016

Senior Notes 7.375%, due 2016

Senior Notes 7.375%, due 2016

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 5.00%, due 2022

Senior Notes 5.00%, due 2022

Senior Notes 5.375%, due 2025

Senior Notes 5.375%, due 2025

Senior Debentures 7.80%, due 2018

Senior Debentures 7.80%, due 2018

Senior Debentures 7.80%, due 2018

Capital leases

Capital leases

Capital leases

Other

Other

Other

New Senior Notes

Term Note

Term Note

Term Note

Term Note

Term Note

Delayed Draw Term Loan

Revolving Credit Facility

Revolving Credit Facility

Multicurrency Revolving Credit Facility

Accounts Receivable Securitization Program

Accounts Receivable Securitization Program

Accounts Receivable Securitization Program

European Accounts Receivable Securitization Program

Minimum

Minimum

Maximum

Maximum

item

USD ($)

USD ($)

USD ($)

Prior Senior Credit Agreement

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

CAD

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Prior Senior Credit Agreement

Prior Senior Credit Agreement

Prior Senior Credit Agreement

New Senior Credit Agreement

New Senior Credit Agreement

New Senior Credit Agreement

Prior Senior Credit Agreement

New Senior Credit Agreement

New Senior Credit Agreement

USD ($)

USD ($)

USD ($)

EUR (€)

New Senior Credit Agreement

New Senior Credit Agreement

New Senior Credit Agreement

New Senior Credit Agreement

USD ($)

USD ($)

CAD

EUR (€)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

Debt Instrument

Total long-term debt

$3,444

$3,412

$3,333

$264

$150

$390

$405

$405

$59

76

$70

$74

$91

€ 85

$103

$116

$18

$18

$621

$597

$596

$594

$539

$608

$688

$356

€ 330

$401

$454

$494

$494

$296

$296

$250

$250

$250

$66

$63

$38

$24

$29

$22

$390

76

€ 85

$600

€ 279

$300

$900

$300

$600

Less amounts due within one year

460

41

361

Long-term debt

2,984

3,371

2,972

250

250

250

Interest rate, stated percentage

3.00%

7.38%

6.75%

4.88%

4.88%

5.00%

5.38%

7.80%

Maximum Borrowing Capacity

215

Unused Credit

558

Weighted Average Interest Rate (as a percent)

1.70%

Face Value

500

300

Interest expense

47

54

7

5

Net proceeds, after deducting debt issuance costs

790

Principal Amount

600

539

356

500

300

250

611

Indicated Market Price (in dollars per share)

$105.88

$120.91

$112.33

$102.63

$103.13

$112.56

Fair Value

635

652

400

513

309

281

Short-term loans and long-term debt due within one year

$637

$331

$488

$171

$122

$253

Weighted average interest rate, short-term debt (as a percent)

1.36%

1.41%

1.53%

Number financial maintenance covenants

1

Leverage ratio as defined in the Agreement

4

Increase in Leverage Ratio as defined in the Agreement

0.5

Number of fiscal quarters following the consummation of certain qualifying acquisitions as defined in the New Agreement

1 year

Interest rate margin, Eurocurrency Rate loans (as a percent)

1.25%

1.75%

Interest rate margin, Base Rate loans (as a percent)

0.25%

0.75%

Facility fee payable (as a percent)

0.20%

0.30%

Contingencies_Details

Contingencies (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Dec. 31, 1993
	item
Percentage of asbestos plaintiffs
Sale of goods containing asbestos from 1948 to 1958	$40,000,000
Approximate number of claims disposed of to date	395,000
Average indemnity payment per claim	8,900
Deferred amounts payable	16,000,000	13,000,000
Asbestos-related liability, total amount accrued beginning in 1993 through 2014 before insurance recoveries		4,400,000,000	975,000,000
Additional estimated period that result in an annual charge, if future comprehensive review of asbestos-related liabilities is not determined	1 year
Asbestos related charges		$135,000,000
Approximate number of plaintiffs and claimants asbestos claims pending against the entity
Number of pending plaintiffs and claimants	2,200
Damages unspecified or sufficient to invoke jurisdictional minimum
Percentage of asbestos plaintiffs
Percentage of asbestos plaintiffs, approximate percentage	81.00%
Damages of $15 million or less
Percentage of asbestos plaintiffs
Percentage of asbestos plaintiffs, approximate percentage	13.00%
Damages greater than $15 million but less than $100 million
Percentage of asbestos plaintiffs
Percentage of asbestos plaintiffs, approximate percentage	5.00%
Damages equal to or greater than $100 million
Percentage of asbestos plaintiffs
Percentage of asbestos plaintiffs, fewer than percentage	1.00%

Share_Owners_Equity_Details

Share Owners' Equity (Details) (USD $)	3 Months Ended		0 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Feb. 05, 2015	Dec. 31, 2014	Feb. 04, 2015	Dec. 31, 2013
Increase (Decrease) in Share Owners' Equity
Balance	$1,275	$1,603
Issuance of common stock (32,179, and 155,727 shares) for the period ended March 31, 2015 and 2014, respectively)		4
Issuance of common stock (in shares)	32,179	155,727
Reissuance of common stock (57,459, and 48,041 shares) for the period ended March 31, 2015 and 2014, respectively)	2	2
Reissuance of common stock (in shares)	57,459	48,041
Treasury shared purchase (3,509,496 shares) for the period ended March 31, 2015	-100
Treasury shares purchased (in shares)	3,509,496
Stock compensation	8	8
Net earnings	75	106
Other comprehensive income (loss)	-220	56
Acquisition of noncontrolling interest	-12
Distributions to noncontrolling interests		-19
Balance	1,028	1,760
Common Stock, Number of Shares, Par Value and Other Disclosures
Common stock, shares authorized	250,000,000
Common stock, par value (in dollars per share)	$0.01
Common stock, shares issued	184,421	183,811		183,915
Treasury stock, shares	23,170	18,738		19,718
J. P. Morgan Securities LLC
Increase (Decrease) in Share Owners' Equity
Treasury shares purchased (in shares)			3,509,496
Repurchase of common stock					100
Percentage of repurchased common stock			85.00%
Parent
Increase (Decrease) in Share Owners' Equity
Net earnings	71	101
Common Stock
Increase (Decrease) in Share Owners' Equity
Balance				2		2
Balance	2	2		2		2
Capital in Excess of Par Value
Increase (Decrease) in Share Owners' Equity
Balance	3,066	3,040
Issuance of common stock (32,179, and 155,727 shares) for the period ended March 31, 2015 and 2014, respectively)		4
Stock compensation	8	8
Acquisition of noncontrolling interest	-18
Balance	3,056	3,052
Treasury Stock
Increase (Decrease) in Share Owners' Equity
Balance	-480	-454
Reissuance of common stock (57,459, and 48,041 shares) for the period ended March 31, 2015 and 2014, respectively)	2	2
Treasury shared purchase (3,509,496 shares) for the period ended March 31, 2015	-100
Balance	-578	-452
Retained Earnings (Loss)
Increase (Decrease) in Share Owners' Equity
Balance	64	-11
Net earnings	71	101
Balance	135	90
Accumulated Other Comprehensive Loss
Increase (Decrease) in Share Owners' Equity
Balance	-1,494	-1,121
Other comprehensive income (loss)	-216	59
Balance	-1,710	-1,062
Non-controlling Interests
Increase (Decrease) in Share Owners' Equity
Balance	117	147
Net earnings	4	5
Other comprehensive income (loss)	-4	-3
Acquisition of noncontrolling interest	6
Distributions to noncontrolling interests		-19
Balance	$123	$130

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Other comprehensive income (loss)	($220)	$56
Net Effect of Exchange Rate Fluctuations
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	-55	229
Change before reclassifications	-253	35
Other comprehensive income (loss)	-253	35
Balance at end of the period	-308	264
Change in Certain Derivative Instruments
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period		-12	-11
Change before reclassifications		2
Amounts reclassified from accumulated other comprehensive income		-1
Other comprehensive income (loss)		1
Balance at end of the period	-11	-11	-11
Employee Benefit Plans
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	-1,428	-1,338
Amounts reclassified from accumulated other comprehensive income	21	23
Translation effect	15	1
Tax effect	1	-1
Other comprehensive income (loss)	37	23
Balance at end of the period	-1,391	-1,315
Accumulated Other Comprehensive Loss
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax
Balance at beginning of the period	-1,494	-1,121
Change before reclassifications	-253	37
Amounts reclassified from accumulated other comprehensive income	21	22
Translation effect	15	1
Tax effect	1	-1
Other comprehensive income (loss)	-216	59
Balance at end of the period	($1,710)	($1,062)

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Net earnings (loss) attributable to the Company	$71	$101
Denominator (in thousands):
Denominator for basic earnings per share - weighted average shares outstanding (in shares)	162,146,000	164,760,000
Effect of dilutive securities:
Stock options and other (in shares)	1,141,000	1,405,000
Denominator for diluted earnings per share - adjusted weighted average shares (in shares)	163,287,000	166,165,000
Basic earnings per share:
Earnings from continuing operations (in dollars per share)	$0.44	$0.62
Loss from discontinued operations (in dollars per share)		($0.01)
Net earnings (in dollars per share)	$0.44	$0.61
Diluted earnings per share:
Earnings from continuing operations (in dollars per share)	$0.44	$0.62
Gain (loss) from discontinued operations (in dollars per share)		($0.01)
Net earnings (in dollars per share)	$0.44	$0.61
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares)	1,798,933	370,012

Supplemental_Cash_Flow_Informa2

Supplemental Cash Flow Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Supplemental Cash Flow Information
Interest paid in cash	$59	$70
Income taxes paid in cash (non-U.S.)	$32	$31

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	3 Months Ended	0 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 10, 2015	Mar. 31, 2015
		item
Subsidiaries
Loss from discontinued operations	$1
Discontinued Operations, Disposed Venezuelan Subsidiaries
Subsidiaries
Loss from discontinued operations	1
Expropriated plants		2
Discontinued Operations, Disposed Venezuelan Subsidiaries | Minimum
Subsidiaries
Litigation Settlement, Amount		455
Discontinued Operations, Disposed Venezuelan Subsidiaries | Maximum
Subsidiaries
Loss from discontinued operations			$1

Financial_Information_for_Subs2

Financial Information for Subsidiary Guarantors and Non-Guarantors (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014
	item
Financial Information for Subsidiary Guarantors and Non-Guarantors
Number of subsidiaries that have guaranteed the notes	2
Ownership percentage in Guarantor Subsidiaries	100.00%
Current assets:
Cash and cash equivalents	$257	$512	$201
Accounts receivable	861	744	1,078
Inventories	1,007	1,035	1,204
Other current assets	74	80	94
Total current assets	2,199	2,371	2,577
Property, plant and equipment, net	2,337	2,445	2,634
Goodwill	1,752	1,893	2,059
Other non-current assets	1,038	1,149	1,218
Total assets	7,326	7,858	8,488
Current liabilities:
Short-term loans and long-term debt due within one year	637	488	331
Current portion of asbestos liability	143	143	150
Accounts payable	919	1,137	1,074
Other liabilities	417	560	527
Total current liabilities	2,116	2,328	2,082
Long-term debt	2,984	2,972	3,371
Asbestos-related liabilities	278	292	283
Other long-term liabilities	920	991	992
Total share owners' equity of the Company	905	1,158	1,630
Noncontrolling interests	123	117	130
Total liabilities and share owners' equity	7,326	7,858	8,488
Eliminations
Current assets:
Investments in and advances to subsidiaries	-2,909	-3,456	-4,376
Total assets	-2,909	-3,456	-4,376
Current liabilities:
Other liabilities	-7	-20
Total current liabilities	-7	-20
Long-term debt	-250	-250	-250
Total share owners' equity of the Company	-2,652	-3,186	-4,126
Total liabilities and share owners' equity	-2,909	-3,456	-4,376
Parent
Current assets:
Investments in and advances to subsidiaries	1,583	1,863	2,313
Total assets	1,583	1,863	2,313
Current liabilities:
Current portion of asbestos liability	143	143	150
Other liabilities	7	20
Total current liabilities	150	163	150
Long-term debt	250	250	250
Asbestos-related liabilities	278	292	283
Total share owners' equity of the Company	905	1,158	1,630
Total liabilities and share owners' equity	1,583	1,863	2,313
Guarantor Subsidiaries
Current assets:
Investments in and advances to subsidiaries	1,326	1,593	2,063
Total assets	1,326	1,593	2,063
Current liabilities:
Total share owners' equity of the Company	1,326	1,593	2,063
Total liabilities and share owners' equity	1,326	1,593	2,063
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	257	512	201
Accounts receivable	861	744	1,078
Inventories	1,007	1,035	1,204
Other current assets	74	80	94
Total current assets	2,199	2,371	2,577
Property, plant and equipment, net	2,337	2,445	2,634
Goodwill	1,752	1,893	2,059
Other non-current assets	1,038	1,149	1,218
Total assets	7,326	7,858	8,488
Current liabilities:
Short-term loans and long-term debt due within one year	637	488	331
Accounts payable	919	1,137	1,074
Other liabilities	417	560	527
Total current liabilities	1,973	2,185	1,932
Long-term debt	2,984	2,972	3,371
Other long-term liabilities	920	991	992
Total share owners' equity of the Company	1,326	1,593	2,063
Noncontrolling interests	123	117	130
Total liabilities and share owners' equity	$7,326	$7,858	$8,488

Financial_Information_for_Subs3

Financial Information for Subsidiary Guarantors and Non-Guarantors (Details 2) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Results of Operations
Net sales	$1,421	$1,639
Cost of goods sold	-1,153	-1,318
Gross profit	268	321
Selling and administrative expense	-124	-133
Research, development and engineering expense	-15	-15
Interest expense, net	-47	-54
Other equity earnings	15	16
Other income (expense), net	3	-1
Earnings from continuing operations before income taxes	100	134
Provision for income taxes	-25	-27
Earnings from continuing operations	75	107
Loss from discontinued operation		-1
Net earnings	75	106
Net earnings attributable to noncontrolling interests	-4	-5
Net earnings attributable to the Company	71	101
Comprehensive Income
Net earnings	75	106
Other comprehensive income (loss)	-220	56
Total comprehensive income (loss)	-145	162
Comprehensive income attributable to noncontrolling interests		-2
Comprehensive income (loss) attributable to the Company	-145	160
Parent
Results of Operations
Interest expense, net	-7	-5
Net intercompany interest	7	5
Equity earnings from subsidiaries	71	101
Earnings from continuing operations before income taxes	71	101
Earnings from continuing operations	71	101
Net earnings	71	101
Net earnings attributable to the Company	71	101
Comprehensive Income
Net earnings	71	101
Other comprehensive income (loss)	-216	59
Total comprehensive income (loss)	-145	160
Comprehensive income (loss) attributable to the Company	-145	160
Guarantor Subsidiaries
Results of Operations
Equity earnings from subsidiaries	71	101
Earnings from continuing operations before income taxes	71	101
Earnings from continuing operations	71	101
Net earnings	71	101
Net earnings attributable to the Company	71	101
Comprehensive Income
Net earnings	71	101
Other comprehensive income (loss)	-216	59
Total comprehensive income (loss)	-145	160
Comprehensive income (loss) attributable to the Company	-145	160
Non-Guarantor Subsidiaries
Results of Operations
Net sales	1,421	1,639
Cost of goods sold	-1,153	-1,318
Gross profit	268	321
Selling and administrative expense	-124	-133
Research, development and engineering expense	-15	-15
Interest expense, net	-40	-49
Net intercompany interest	-7	-5
Other equity earnings	15	16
Other income (expense), net	3	-1
Earnings from continuing operations before income taxes	100	134
Provision for income taxes	-25	-27
Earnings from continuing operations	75	107
Loss from discontinued operation		-1
Net earnings	75	106
Net earnings attributable to noncontrolling interests	-4	-5
Net earnings attributable to the Company	71	101
Comprehensive Income
Net earnings	75	106
Other comprehensive income (loss)	-220	56
Total comprehensive income (loss)	-145	162
Comprehensive income attributable to noncontrolling interests		-2
Comprehensive income (loss) attributable to the Company	-145	160
Eliminations
Results of Operations
Interest expense, net	-142
Equity earnings from subsidiaries		-202
Earnings from continuing operations before income taxes	-142	-202
Earnings from continuing operations	-142	-202
Net earnings	-142	-202
Net earnings attributable to the Company	-142	-202
Comprehensive Income
Net earnings	-142	-202
Other comprehensive income (loss)	432	-118
Total comprehensive income (loss)	290	-320
Comprehensive income (loss) attributable to the Company	$290	($320)

Financial_Information_for_Subs4

Financial Information for Subsidiary Guarantors and Non-Guarantors (Details 3) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash Flows
Total cash utilized in operating activities	($278)	($203)
Cash utilized in investing activities	-157	-94
Cash provided by financing activities	207	121
Effect of exchange rate fluctuations on cash	-27	-6
Decrease in cash	-255	-182
Cash at beginning of period	512	383
Cash at end of period	257	201
Parent
Cash Flows
Total cash utilized in operating activities	-15	-15
Cash provided by financing activities	15	15
Non-Guarantor Subsidiaries
Cash Flows
Total cash utilized in operating activities	-263	-188
Cash utilized in investing activities	-157	-94
Cash provided by financing activities	192	106
Effect of exchange rate fluctuations on cash	-27	-6
Decrease in cash	-255	-182
Cash at beginning of period	512	383
Cash at end of period	$257	$201